These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30122987)

  • 1. Lack of association between the risk of prostate cancer and vitamin D receptor
    Kang S; Zhao Y; Wang L; Liu J; Chen X; Liu X; Shi Z; Gao W; Cao F
    Cancer Manag Res; 2018; 10():2377-2387. PubMed ID: 30122987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk.
    Zeng XT; Yao QS; Weng H; Li S; Huang JY; Wang XH
    Mol Biol Rep; 2014 Oct; 41(10):6713-7. PubMed ID: 24990700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects.
    Guo Z; Wen J; Kan Q; Huang S; Liu X; Sun N; Li Z
    Tumour Biol; 2013 Oct; 34(5):3189-200. PubMed ID: 23807674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis.
    Lu Y; Liu Y; Zeng J; He Y; Peng Q; Deng Y; Wang J; Xie L; Li T; Qin X; Li S
    Tumour Biol; 2014 May; 35(5):3997-4005. PubMed ID: 24488627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis.
    Zhu W; Liu H; Wang X; Lu J; Zhang H; Wang S; Yang W
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30765615
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis.
    Ruan L
    Medicine (Baltimore); 2024 Mar; 103(9):e37361. PubMed ID: 38428858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the vitamin D receptor gene polymorphisms and diabetic nephropathy risk: A meta-analysis.
    Yin F; Liu J; Fan MX; Zhou XL; Zhang XL
    Nephrology (Carlton); 2018 Feb; 23(2):107-116. PubMed ID: 28703918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in
    Liu Y; Hu Y; Zhang M; Jiang R; Liang C
    J Cancer; 2018; 9(16):2786-2794. PubMed ID: 30123346
    [No Abstract]   [Full Text] [Related]  

  • 9. The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: a pooled analysis of 41 sets of data from case-control studies.
    Chen Y; Li T; Yu X; Xu J; Li J; Luo D; Mo Z; Hu Y
    Gene; 2014 Jan; 534(2):286-97. PubMed ID: 24177231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
    Ma Q; Qi C; Tie C; Guo Z
    Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of VDR polymorphisms ( Taq I and Bsm I) with prostate cancer: a new meta-analysis.
    Liu S; Cai H; Cheng W; Zhang H; Pan Z; Wang D
    J Int Med Res; 2017 Feb; 45(1):3-10. PubMed ID: 28222630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between MMP-2 expression and prostate cancer: A meta-analysis.
    Xie T; Dong B; Yan Y; Hu G; Xu Y
    Biomed Rep; 2016 Feb; 4(2):241-245. PubMed ID: 26893846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor BsmI polymorphism and osteoporosis risk in post-menopausal women.
    Zhao B; Zhang W; Du S; Zhou Z
    Arch Med Sci; 2016 Feb; 12(1):25-30. PubMed ID: 26925115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysis.
    Wang F; Qin Z; Si S; Tang J; Xu L; Xu H; Li R; Han P; Yang H
    Oncotarget; 2017 Aug; 8(34):57440-57450. PubMed ID: 28915684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitamin D receptor gene Bsm I polymorphism and the susceptibility to prostate cancer in northern Chinese Han population].
    Liu JH; Li HW; Wang JQ; Li M; Xin DQ; Na X; Zhang M; Ye SY; Na YQ
    Zhonghua Nan Ke Xue; 2003 Sep; 9(6):413-6. PubMed ID: 14574802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The vitamin D receptor gene Tru I polymorphisms and its effect on the detection of Bsm I polymorphisms in Han nationality].
    Chen WJ; Ye W; Su PQ; Ding Y; Peng Y; Liang AJ; Huang DS; Li GT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):338-40. PubMed ID: 17557252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of vitamin D receptor BsmI rs1544410 and ApaI rs7975232 polymorphisms with susceptibility to adolescent idiopathic scoliosis: A systematic review and meta-analysis.
    Yin X; Wang H; Guo J; Zhang L; Zhang Y; Li L; Hou S
    Medicine (Baltimore); 2018 Jan; 97(2):e9627. PubMed ID: 29480871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysis.
    Qin Z; Li X; Tang J; Jiang X; Yu Y; Wang C; Xu W; Hua Y; Yu B; Zhang W
    Onco Targets Ther; 2016; 9():5451-9. PubMed ID: 27660462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.
    Wang K; Wu G; Li J; Song W
    BMC Cancer; 2016 Aug; 16(1):674. PubMed ID: 27553621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor Bsm I polymorphism and osteoporosis risk in postmenopausal women: a meta-analysis from 42 studies.
    Liao JL; Qin Q; Zhou YS; Ma RP; Zhou HC; Gu MR; Feng YP; Wang BY; Yang L
    Genes Nutr; 2020 Nov; 15(1):20. PubMed ID: 33238893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.